Microbot Medical Inc
MBOT
Get informed when a big investor buys or sells
+ FollowMarket Cap$65.41M
Close$
$0.07
93.2% downside
Current Fair Value
93.2% downsideOvervalued by 93.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $65.41 Million |
|---|---|
| Enterprise Value | $63.14 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.29 |
| Beta | 1.05 |
| Outstanding Shares | 67,163,613 |
Return
| Return on Equity | -11.84% |
|---|---|
| Return on Assets | -11.12% |
| Return on Invested Capital | -19.88% |
Valuation & Multiples
| P/E Ratio | -3.74 |
|---|---|
| PEG | -6.15 |
| Price to Sales | - |
| Price to Book Ratio | 0.97 |
| Enterprise Value to Revenue | 182.47 |
| Enterprise Value to EBIT | -4.57 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$133,333
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$916,667
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 88.70% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.05%▼ 16.91% |
|---|---|
| Total Invested | $38,422▼ 99.83% |
| Investors Holding | 2▼ 74.00% |
ESG Score
No data
About Microbot Medical Inc
15 employees
CEO: Harel Gadot Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot's current proprietary...